In this study, we analyze the expression levels of CD276 in NSCLC cell lines, while also validating a newly developed Fc-optimized CD276 monoclonal antibody, known as 8H8_SDIE, which enhances NK cell activity and cytotoxicity against NSCLC. The gene discussed is CD276; the disease is non-small cell lung carcinoma.